This inventor holds 2 USPTO granted patents. Top assignee: Beckman Research Institute, City of Hope. Active years: 2011-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2012
Title: Innovations of Bing-Sen Zhou
Introduction
Bing-Sen Zhou is a notable inventor based in West Covina, California. He has made significant contributions to the field of biochemistry, particularly in the development of ribonucleotide reductase inhibitors. With a total of two patents to his name, Zhou's work has the potential to impact the treatment of various diseases.
Latest Patents
Zhou's latest patents focus on novel compounds that inhibit ribonucleotide reductase (RR) by binding to RRM2. This binding interferes with the activity of the RRM1/RRM2 holoenzyme. These inhibitors may be utilized to inhibit RR activity and treat conditions associated with RRM2 expression, including certain cancer types, mitochondrial diseases, and degenerative diseases.
Career Highlights
Bing-Sen Zhou is currently affiliated with City of Hope, a prominent research and treatment center. His work at this institution has allowed him to explore innovative solutions in the realm of cancer treatment and other serious health conditions.
Collaborations
Zhou has collaborated with esteemed colleagues such as Yun Yen and David A. Horne. These partnerships have fostered a collaborative environment that enhances research and development efforts.
Conclusion
Bing-Sen Zhou's contributions to the field of biochemistry through his patents on ribonucleotide reductase inhibitors highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for potential treatments for serious health conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile